XML 114 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Restructuring, Impairment and Other Charges (Tables)
6 Months Ended
Jun. 30, 2013
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
The following table summarizes the impact of the Company’s restructuring charges (accrual adjustments) on the condensed consolidated statements of operations:
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2013
 
2012
 
2013
 
2012
Cost of sales – services
 
$
4,235

 
$
(196
)
 
$
6,859

 
$
(865
)
Cost of sales – products
 
78

 
100

 
217

 
105

Selling and administrative expense
 
1,629

 
813

 
7,516

 
3,200

Research, development and engineering expense
 
1,613

 

 
2,466

 

Total
 
$
7,555

 
$
717

 
$
17,058

 
$
2,440

Restructuring charges (accrual adjustments) within continuing operations for DNA and DI reporting segments
The following table summarizes the Company’s net restructuring charges for its Diebold North America (DNA) and Diebold International (DI) reporting segments:
 
 
Three Months Ended
 
Six Months Ended
 
 
June 30,
 
June 30,
 
 
2013
 
2012
 
2013
 
2012
DNA
 
 
 
 
 
 
 
 
Severance
 
$
3,883

 
$
450

 
$
13,411

 
$
1,557

DI
 
 
 
 
 
 
 
 
Severance
 
3,593

 
164

 
3,507

 
292

Other
 
79

 
103

 
140

 
591

Total
 
$
7,555

 
$
717

 
$
17,058

 
$
2,440



Restructuring accrual balances and related activity
The following table summarizes the Company’s restructuring accrual balances:
 
 
2013
 
2012
Balance at January 1
 
$
11,844

 
$
10,136

Liabilities incurred
 
17,058

 
2,440

Liabilities paid
 
(17,788
)
 
(3,587
)
Balance at June 30
 
$
11,114

 
$
8,989